These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29735188)

  • 21. Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma.
    Hoppe BS; Mamalui-Hunter M; Mendenhall NP; Li Z; Indelicato DJ
    Am J Clin Oncol; 2013 Feb; 36(1):31-7. PubMed ID: 22134517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.
    Dionisi F; Avery S; Lukens JN; Ding X; Kralik J; Kirk M; Roses RE; Amichetti M; Metz JM; Plastaras JP
    Acta Oncol; 2014 Oct; 53(10):1312-20. PubMed ID: 24797885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
    Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
    Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
    Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
    Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal tissue complications from low-dose proton therapy.
    Mahajan A
    Health Phys; 2012 Nov; 103(5):586-9. PubMed ID: 23032888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
    Seco J; Panahandeh HR; Westover K; Adams J; Willers H
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
    Thompson RF; Mayekar SU; Zhai H; Both S; Apisarnthanarax S; Metz JM; Plastaras JP; Ben-Josef E
    Med Phys; 2014 Aug; 41(8):081711. PubMed ID: 25086521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.
    Arians N; Lindel K; Krisam J; Herfarth K; Krug D; Akbaba S; Oelmann-Avendano J; Debus J
    Radiat Oncol; 2017 Nov; 12(1):188. PubMed ID: 29179751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particle Radiation Therapy for Gastrointestinal Cancers.
    Shinoto M; Ebner DK; Yamada S
    Curr Oncol Rep; 2016 Mar; 18(3):17. PubMed ID: 26849660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection.
    Wu XY; Chen M; Cao L; Li M; Chen JY
    Technol Cancer Res Treat; 2024; 23():15330338241234788. PubMed ID: 38389426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.
    van de Schoot AJ; de Boer P; Crama KF; Visser J; Stalpers LJ; Rasch CR; Bel A
    Acta Oncol; 2016 Jul; 55(7):892-9. PubMed ID: 26934821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.